f your eyes have become significantly drier, more irritated, or more uncomfortable in the years around menopause, you're not imagining it and you're not alone. The hormonal changes of perimenopause and menopause have direct effects on the tear film and the glands that maintain it.

How hormones affect the tear film

Sex hormones — particularly oestrogen, progesterone, and androgens — play significant roles in the health of the lacrimal gland, the meibomian glands, and the conjunctival goblet cells that collectively maintain the tear film.

Androgens and the meibomian glands Androgen receptors are present in meibomian glands, and androgen signalling is important for normal gland function and secretion. Androgen levels decline with age in both men and women — but the decline is more pronounced and more rapid in women during and after menopause. Reduced androgen stimulation is associated with reduced meibomian gland function and poorer quality meibomian oil — contributing directly to evaporative dry eye.

Oestrogen and lacrimal gland function The relationship between oestrogen and dry eye is complex and not fully resolved by the research. Some studies suggest oestrogen has a protective effect on lacrimal gland function; others suggest that oestrogen supplementation worsens dry eye symptoms in some women. What is clear is that the hormonal shift of menopause — rather than any single hormone in isolation — disrupts the carefully balanced ocular surface environment.

Goblet cell and mucin layer changes Hormonal changes affect conjunctival goblet cell density and function, which influences the mucin layer of the tear film. Reduced mucin production destabilises the tear film and increases ocular surface exposure.

When symptoms typically appear

Dry eye symptoms related to hormonal change often emerge during perimenopause — sometimes before other menopausal symptoms are recognised — and tend to worsen through the menopausal transition. Many women who have managed comfortably with contact lenses for years find lens tolerance suddenly decreasing during this period.

Post-menopausally, without treatment, dry eye tends to be a persistent condition rather than a temporary one — the hormonal environment that maintained tear film health has changed permanently.

HRT and dry eye

The relationship between hormone replacement therapy and dry eye is nuanced — covered in more detail on our HRT & the Tear Film page. The short version is that HRT may help some aspects of ocular surface health while potentially worsening others, and the picture varies between individuals and formulations.

What can be done?

The menopausal changes driving dry eye are real and clinically significant — and they respond to the same specialist treatments that work for other presentations of dry eye disease.

IPL therapy reduces the inflammation driving meibomian gland dysfunction regardless of its hormonal origin. LLLT supports gland function and reduces lid margin disease. A structured treatment programme combined with appropriate home care can produce significant improvement in menopausal dry eye.

We'd also encourage discussion with your GP about the broader management of menopausal symptoms — ocular surface health is one component of a wider picture.

Find out more about IPL → Find out more about LLLT →

📍 Openshaw Opticians, Unit 4, 16 Cheapside, Cleckheaton, BD19 5AF 

📞 01274 878214